A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Clinical trial NCT03558152 · COMPLETED
Trial details
- NCT number
- NCT03558152
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2021-12-15
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.